Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers
Batel Blechter,Xiaoyu Wang,Jianxin Shi,Kouya Shiraishi,Jiyeon Choi,Keitaro Matsuo,Tzu-Yu Chen,Juncheng Dai,Rayjean J Hung,Kexin Chen,Xiao-Ou Shu,Young Tae Kim,Parichoy Pal Choudhury,Jacob Williams,Maria Teresa Landi,Dongxin Lin,Wei Zheng,Zhihua Yin,Bao Song,I-Shou Chang,Yun-Chul Hong,Never Smoker Lung Cancer Working Group,Nilanjan Chatterjee,Olga Y Gorlova,Christopher I Amos,Hongbing Shen,Chao Agnes Hsiung,Stephen J Chanock,Nathaniel Rothman,Takashi Kohno,Qing Lan,Haoyu Zhang
DOI: https://doi.org/10.1101/2024.06.26.24309127
2024-06-27
Abstract:Background
Lung adenocarcinoma (LUAD) among never-smokers is a public health burden especially prevalent in East Asian (EAS) women. Polygenic risk scores (PRSs), which quantify genetic susceptibility, are promising for stratifying risk, yet have mainly been developed in European (EUR) populations. We developed and validated single-and multi-ancestry PRSs for LUAD in EAS never-smokers, using the largest available genome-wide association study (GWAS) dataset.
Methods
We used GWAS summary statistics from both EAS (8,002 cases; 20,782 controls) and EUR (2,058 cases; 5,575 controls) populations, as well as independent EAS individual level data. We evaluated several PRSs approaches: a single-ancestry PRS using 25 variants that reached genome-wide significance (PRS-25), a genome-wide Bayesian based approach (LDpred2), and a multi-ancestry approach that models genetic correlations across ancestries (CT-SLEB). PRS performance was evaluated based on the association with LUAD and AUC values. We then estimated the lifetime absolute risk of LUAD (age 30-80) and projected the AUC at different sample sizes using EAS-derived effect-size distribution and heritability estimates.
Findings
The CT-SLEB PRS showed a strong association with LUAD risk (odds ratio=1.71, 95% confidence interval (CI): 1.61, 1.82) with an AUC of 0.640 (95% CI: 0.629, 0.653). Individuals in the 95th percentile of the PRS had an estimated 6.69% lifetime absolute risk of LUAD. Comparison of LUAD risk between individuals in the highest and lowest 20% PRS quantiles revealed a 3.92-fold increase. Projection analyses indicated that achieving an AUC of 0.70, which approaches the maximized prediction potential of the PRS given the estimated genetic variance, would require a future study encompassing 55,000 EAS LUAD cases with a 1:10 case-control ratio.
Interpretations
Our study underscores the potential of multi-ancestry PRS approaches to enhance LUAD risk stratification in never-smokers, particularly in EAS populations, and highlights the necessary scale of future research to uncover the genetic underpinnings of LUAD.
Genetic and Genomic Medicine